New York Sues Former C.E.O. of Covid Vaccine Maker Over Insider Trading
Robert G. Kramer sold nearly 90,000 shares of his stock [...]
Trial of Controversial Alzheimer’s Drug Halted After Disappointing Results
Cassava Sciences said that its drug did not significantly reduce [...]
Officials Cast Doubt on a Dementia Drug, but Human Trials Continue
The S.E.C. alleged shortcomings in research said to support the [...]
Executives Depart Cassava, Maker of Disputed Alzheimer’s Drug
The chief executive and a lead scientist stepped down weeks [...]
Scientists Investigating Alzheimer’s Drug Faulted in Leaked Report
A professor at the City College of New York engaged [...]